98 related articles for article (PubMed ID: 2506661)
1. Multicenter pilot study of the efficacy and safety of systemic rt-PA administration in the treatment of deep vein thrombosis of the lower extremities and/or pelvis.
Verhaeghe R; Besse P; Bounameaux H; Marbet GA
Thromb Res; 1989 Jul; 55(1):5-11. PubMed ID: 2506661
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis.
Goldhaber SZ; Meyerovitz MF; Green D; Vogelzang RL; Citrin P; Heit J; Sobel M; Wheeler HB; Plante D; Kim H
Am J Med; 1990 Mar; 88(3):235-40. PubMed ID: 2106783
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, randomized comparison of systemic continuous infusion of 0.25 versus 0.50 mg/kg/24 h of alteplase over 3 to 7 days for treatment of deep venous thrombosis in heparinized patients: results of the European Thrombolysis with rt-PA in Venous Thrombosis (ETTT) trial.
Bounameaux H; Banga JD; Bluhmki E; Coccheri S; Fiessinger JN; Haarmann W; Lockner D; Mahler F; Ninet J; Schneider PA
Thromb Haemost; 1992 Mar; 67(3):306-9. PubMed ID: 1641820
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial.
Turpie AG; Levine MN; Hirsh J; Ginsberg JS; Cruickshank M; Jay R; Gent M
Chest; 1990 Apr; 97(4 Suppl):172S-175S. PubMed ID: 2108855
[TBL] [Abstract][Full Text] [Related]
5. [Randomized double-blind study comparing tissue-type plasminogen activator with placebo in acute myocardial infarct].
Bleifeld W; Verstraete M; Brower RW; Collen D; Dunning AJ; Lubsen J; Michel PL; Schofer J; Vanhaecke J; Van de Werf F
Klin Wochenschr; 1988; 66 Suppl 12():86-92. PubMed ID: 3126349
[TBL] [Abstract][Full Text] [Related]
6. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).
Wilcox RG; von der Lippe G; Olsson CG; Jensen G; Skene AM; Hampton JR
Lancet; 1988 Sep; 2(8610):525-30. PubMed ID: 2900919
[TBL] [Abstract][Full Text] [Related]
7. [Thrombolytic therapy of deep venous thrombosis with rt-PA].
Zimmermann R; Horn A; Harenberg J; Diehm C; Müller-Bühl U; Kübler W
Klin Wochenschr; 1988; 66 Suppl 12():137-42. PubMed ID: 3126342
[TBL] [Abstract][Full Text] [Related]
8. Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study.
Schweizer J; Elix H; Altmann E; Hellner G; Forkmann L
Vasa; 1998 Aug; 27(3):167-71. PubMed ID: 9747153
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator for the treatment of acute pulmonary embolism. A collaborative study by the PIOPED Investigators.
Chest; 1990 Mar; 97(3):528-33. PubMed ID: 2106408
[TBL] [Abstract][Full Text] [Related]
10. Comparison of dosage schedules of rt-PA in the treatment of proximal deep vein thrombosis.
Marder VJ; Brenner B; Totterman S; Francis CW; Rubin R; Rao AK; Kessler CM; Kwaan HC; Sharma GV; Fong KL
J Lab Clin Med; 1992 May; 119(5):485-95. PubMed ID: 1583404
[TBL] [Abstract][Full Text] [Related]
11. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
[TBL] [Abstract][Full Text] [Related]
12. A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism.
Levine M; Hirsh J; Weitz J; Cruickshank M; Neemeh J; Turpie AG; Gent M
Chest; 1990 Dec; 98(6):1473-9. PubMed ID: 2123152
[TBL] [Abstract][Full Text] [Related]
13. Thrombolysis in myocardial infarction (TIMI): update 1987.
Mueller HS
Klin Wochenschr; 1988; 66 Suppl 12():93-101. PubMed ID: 3126350
[TBL] [Abstract][Full Text] [Related]
14. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
Hacke W; Kaste M; Fieschi C; Toni D; Lesaffre E; von Kummer R; Boysen G; Bluhmki E; Höxter G; Mahagne MH
JAMA; 1995 Oct; 274(13):1017-25. PubMed ID: 7563451
[TBL] [Abstract][Full Text] [Related]
15. [Comparative randomized study of the effectiveness of intravenous recombinant tissue-type plasminogen activator and intravenous streptokinase in patients with acute myocardial infarct. Report of the European Cooperative Study Group for Recombinant Tissue-Type Plasminogen Activator].
Verstraete M; Bory M; Collen D; Erbel R; Lennane RJ; Mathey D; Michels HR; Schartl M; Uebis R; Bernard R
Klin Wochenschr; 1988; 66 Suppl 12():77-85. PubMed ID: 3126348
[TBL] [Abstract][Full Text] [Related]
16. Fibrinolytic therapy of deep vein thrombosis with continuous intravenous infusion of a recombinant tissue plasminogen activator.
Zimmerman R; Gürsoy A; Horn A; Harenberg J; Diehm C; Kübler W
Semin Thromb Hemost; 1991 Jan; 17(1):48-54. PubMed ID: 1904629
[TBL] [Abstract][Full Text] [Related]
17. Urokinase or heparin in the management of patients with deep vein thrombosis?
Kiil J; Carvalho A; Saksø P; Nielsen HO
Acta Chir Scand; 1981; 147(7):529-32. PubMed ID: 7048826
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator for the treatment of deep venous thrombosis of the lower extremity: a systematic review.
Forster A; Wells P
Chest; 2001 Feb; 119(2):572-9. PubMed ID: 11171740
[TBL] [Abstract][Full Text] [Related]
19. Combination Therapy Stroke Trial: recombinant tissue-type plasminogen activator with/without lubeluzole.
Grotta J;
Cerebrovasc Dis; 2001; 12(3):258-63. PubMed ID: 11641593
[TBL] [Abstract][Full Text] [Related]
20. Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomized trial. The Bolus Alteplase Pulmonary Embolism Group.
Goldhaber SZ; Agnelli G; Levine MN
Chest; 1994 Sep; 106(3):718-24. PubMed ID: 8082347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
